ICVTS Click here to goto Smart Canula website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Interact CardioVasc Thorac Surg 2008;7:382. doi:10.1510/icvts.2007.169086A
© 2008 European Association of Cardio-Thoracic Surgery

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Google Scholar
Right arrow Articles by Knobloch, K.
Right arrow Articles by Vogt, P. M.
PubMed
Right arrow Articles by Knobloch, K.
Right arrow Articles by Vogt, P. M.
Related Collections
Right arrowRelated Article

eComment

HIT in OPCAB surgery

Karsten Knobloch, Andreas Gohritz, Marcus Spies and Peter M. Vogt

Plastic, Hand and Reconstructive Surgery, Hannover Medical School, Hannover 30625, Germany

Different anticoagulation strategies in off-pump coronary artery bypass operations: a European survey

Given the fact that 78% of the respondent surgeons use low or high molecular weight heparin for perioperative prophylaxis of thrombosis, potential adverse effects of heparin should be considered [1].

As such, thrombocytopenia is a common problem in cardiovascular patients, and heparin-induced thrombocytopenia (HIT) is therefore frequently suspected following cardiac surgery. Currently, is it not clear whether OPCAB surgery is associated with the same or a different incidence of HIT I or HIT II in contrast to on-pump cardiac surgery.

It has been suggested that both functional (platelet activation tests) and immunologic assays (antigen assays) are necessary in every patient to establish the diagnosis of HIT. Screening with thromboelastography has been proposed recently [2]. The prevalence of heparin/platelet factor 4 antibodies is currently under investigation. As far as cardiac surgery is concerned, the high prevalence of antibodies to the heparin/PF4 complex after cardiac surgery and the low rate of thromboembolic complications in this population suggest that the antibody alone does not confer an increased risk of thrombotic complications [3]. This is supported by a recent retrospective analysis [4]. The authors concluded that postoperative platelet count fall between days 5 and 10 increases diagnostic specificity for HIT, irrespective of whether this platelet count fall occurs after postoperative platelet count recovery or is superimposed upon persisting postoperative thrombocytopenia.

A recent survey among 487 cardiac surgery patients with postoperative thrombocytopenia (50% drop in platelet count or absolute count <100,000/µl) at least one enzyme-linked immunosorbent assay for HIT platelet factor 4 antibodies was performed [5]. Postoperative infections occurred more frequently in HITq patients, including sepsis and pneumonia. The HIT+ patients also had a higher rate of renal failure requiring hemodialysis and acute limb ischemia. Thirty-day mortality was significantly higher in the HIT+ group (24.8% vs. 15.2%, P=0.019). Postoperative HIT emerged as an independent predictor of renal failure (OR=1.73, P<0.001) and thromboembolic complications (OR=2.39, P=0.02). In conclusion, greater awareness of the potential devastating sequelae may allow earlier detection of HIT in OPCAB as well as in on-pump cardiac surgery.


    References
 Top
 References
 

  1. Englberger L, Streich M, Tevaearai HT, Carrel TP. Different anticoagulation strategies in off-pump coronary artery bypass operations: a European survey. Interact Cardiovasc Thorac Surg 2008;7:378–383.[Abstract/Free Full Text]
  2. Kouerinis IA, Kourtesis A, El-Ali M, Sergentanis T, Plagou A, Argiriou M, Theakos N, Giannakopoulou A. Heparin induced thrombocytopenia diagnosis in cardiac surgery: is there a role for thromboelastography? Interact Cardiovasc Thorac Surg, doi: 10.1510/icvts.2007.161679.[Abstract]
  3. Everett BM, Yeh R, Foo SY, Criss D, Van Cott EM, Laposata M, Avery EG, Hoffman WD, Walker J, Torchiana D, Jang IK. Prevalence of heparin/platelet factor 4 antibodies before and after cardiac surgery. Ann Thorac Surg 2007;83:592–597.[Abstract/Free Full Text]
  4. Selleng S, Selleng K, Wollert HG, Muellejans B, Lietz T, Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia in patients requiring prolonged intensive care unit treatment after cardiopulmonary bypass. J Thromb Haemost 2008;6:428–435.[CrossRef][Medline]
  5. Kerendi F, Thourani VH, Puskas JD, Kilgo PD, Osgood M, Guyton RA, Lattouf OM. Impact of heparin-induced thrombocytopenia on postoperative outcomes after cardiac surgery. Ann Thorac Surg 2007;84:1548–1553.[Abstract/Free Full Text]

Related Article

Different anticoagulation strategies in off-pump coronary artery bypass operations: a European survey
, , , and
Interactive CardioVascular and Thoracic Surgery 7: 378-382. [Full Text]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Google Scholar
Right arrow Articles by Knobloch, K.
Right arrow Articles by Vogt, P. M.
PubMed
Right arrow Articles by Knobloch, K.
Right arrow Articles by Vogt, P. M.
Related Collections
Right arrowRelated Article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS